This CPD video, delivered in partnership with Mivision and Eyerising International, will explore the real-world application of repeated low-level red-light (RLRL) therapy in clinical practice in Australia. Delivered live online, the session brings together leading experts in ophthalmology and optometry who will share practical insights, case studies, and their perspectives on the role of RLRL therapy in myopia management.
Firstly, ophthalmologist Dr Loren Rose will present an overview of her experience with RLRL in treatment-resistant high myopia, including her clinical observations, real-world outcomes and considerations when incorporating RLRL into patient care and monitoring its efficacy and safety. She will also discuss the emerging evidence, safety considerations and tolerability, and the combination use of RLRL with existing myopia control treatments.
Next, optometrist Philip Cheng will share insights into his clinical journey with RLRL, providing a practical lens into his patient selection, communication strategies with parents and families, and integration of RLRL into his comprehensive myopia management practice. With years of experience in orthokeratology, specialty lenses, and myopia control, Philip will offer actionable takeaways for practitioners considering RLRL in their own clinics and where it fits in alongside existing options.
LEARNING OBJECTIVES
On completion of this CPD article participants should be able to:
1. Describe the mechanism of action, clinical rationale, and current evidence supporting repeated low-level red-light therapy in myopia management,
2. Evaluate case examples and real-world clinical outcomes to identify appropriate patient selection criteria for RLRL, and
3. Integrate practical strategies for introducing RLRL into clinical workflows, including patient/parent communication, monitoring, and safety considerations.
